ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NIH trial to evaluate antibody therapy for Covid-19 treatment
April 23, 2021The National Institutes of Health (NIH) has commenced subject enrolment in a Phase II/III ACTIV-2 trial of a new fully human polyclonal antibody therapeutic called SAB-185 for treating Covid-19 in non-hospitalised individuals with mild or moderate ... -
Synairgen’s inhaled COVID-19 treatment included in US trial
February 25, 2021Synairgen’s inhaled interferon beta-1a treatment, SNG001, has been selected for inclusion in the US government-funded ACTIV-2 trial in COVID-19 outpatients. -
eTrueNorth Recruiting COVID-Positive Individuals for ACTIV-2 Clinical Trial
December 15, 2020eTrueNorth, the U.S.-based healthcare technology company that enables laboratory testing at retail pharmacies and enables all surge drive-through COVID-19 specimen collection sites, will begin proactively communicating with COVID-19 positive ...
Pharma Sources Insight January 2025
